These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 821420)

  • 21. [Clinical experiences with bretylium tosylate].
    Steffen V; Assmann I; Fiehring H
    Z Gesamte Inn Med; 1976 Sep; 31(17):684-8. PubMed ID: 793213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and Purkinje fibers.
    Bigger JT; Jaffe CC
    Am J Cardiol; 1971 Jan; 27(1):82-92. PubMed ID: 5099592
    [No Abstract]   [Full Text] [Related]  

  • 23. Electrophysiologic effects of bretylium tosylate on single fibers of the canine specialized conducting system and ventricle.
    Wit AL; Steiner C; Damato AN
    J Pharmacol Exp Ther; 1970 Jun; 173(2):344-56. PubMed ID: 4393574
    [No Abstract]   [Full Text] [Related]  

  • 24. ELectrophysiologic properties of bretylium tosylate on atrial myocardium.
    Mirro MJ; Webel RR; Kelly KJ; Grina LA
    J Cardiovasc Pharmacol; 1981; 3(6):1312-20. PubMed ID: 6173532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of bretylium tosylate on electrophysiologic properties of normal and digitalized papillary muscles of guinea pigs.
    Liu YC; Zhu PJ; Li ZY; Yu DZ
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):526-8. PubMed ID: 8010051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The anti-arrhythmia properties of ketamine. Preliminary observations on the electrophysiological effects of the drug in humans by means of registration of right atrial monophasic action potentials and the His bundle electrogram].
    Fenici R; Schiavello R; Marchei M
    Minerva Anestesiol; 1977 Sep; 43(9):487-93. PubMed ID: 927669
    [No Abstract]   [Full Text] [Related]  

  • 28. The electrophysiologic effects of nicardipine hydrochloride in man.
    Schwartz AB; Moskowitz RM; Klausner SC
    Can J Cardiol; 1987; 3(1):14-7. PubMed ID: 3828891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bretylium tosylate as an anti-arrhythmic drug].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1976 Nov; 31(22):913-9. PubMed ID: 798429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential blockade of chronotropic responses to cardiac sympathetic nerve stimulation with bretylium.
    Priola DV; Weiss GK; Spurgeon HA
    Proc West Pharmacol Soc; 1977; 20():421-6. PubMed ID: 896849
    [No Abstract]   [Full Text] [Related]  

  • 32. Mexiletine action on the specialized tissues of the human heart.
    Pozzoni L; Romano S; Beltrami A; Calosso E; Verzoni A; Longoni A; Croce L
    Int J Clin Pharmacol Res; 1985; 5(4):229-36. PubMed ID: 4055166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bretylium tosylate on ventricular fibrillation threshold during hypothermia in dogs.
    Bjørnstad H; Mortensen E; Sager G; Refsum H
    Am J Emerg Med; 1994 Jul; 12(4):407-12. PubMed ID: 8031422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the verapamil-induced changes in conductivity and refractoriness and monophasic action potentials of the dog heart in situ.
    Landmark K; Amlie JP
    Eur J Cardiol; 1976 Dec; 4(4):419-27. PubMed ID: 1001337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiologic effects of propafenone in subjects with pre-existing excito-conduction disorders].
    Rizzo A; Fiorilli R; Lisanti P
    G Ital Cardiol; 1984 May; 14(5):377-8. PubMed ID: 6468820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bretylium tosylate: a review.
    Bryan CK; Darby MH
    Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial electrophysiologic effects of bretylium in man and their correlation with plasma concentrations.
    Anderson JL; Brodine WN; Patterson E; Marshall HW; Allison SD; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(6):871-82. PubMed ID: 6185777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiology of tiapamil in humans.
    Lévy S; Burtey JP; Labrunie P; Faugère G; Valeix B; Cano JP; Gérard R
    Cardiology; 1982; 69 Suppl():117-23. PubMed ID: 7151072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological effects of intravenous dantrolene on canine heart.
    Roewer N; Kuck KH; Kochs E; Schulte am Esch J
    Eur J Anaesthesiol; 1987 Sep; 4(5):357-67. PubMed ID: 3428281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
    Slack JD; Rizk AE; Wright KE
    Heart Lung; 1979; 8(4):721-7. PubMed ID: 378903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.